Fennec Pharmaceuticals (TSX:FRX) Other Operating Expense : C$0.29 Mil (TTM As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Fennec Pharmaceuticals Other Operating Expense?

Fennec Pharmaceuticals's Other Operating Expense for the three months ended in Dec. 2023 was C$0.09 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.29 Mil.

Fennec Pharmaceuticals's quarterly Other Operating Expense increased from Jun. 2023 (C$-0.00 Mil) to Sep. 2023 (C$0.10 Mil) but then declined from Sep. 2023 (C$0.10 Mil) to Dec. 2023 (C$0.09 Mil).

Fennec Pharmaceuticals's annual Other Operating Expense increased from Dec. 2021 (C$-0.00 Mil) to Dec. 2022 (C$0.20 Mil) and increased from Dec. 2022 (C$0.20 Mil) to Dec. 2023 (C$0.39 Mil).

Fennec Pharmaceuticals Other Operating Expense Historical Data

The historical data trend for Fennec Pharmaceuticals's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fennec Pharmaceuticals Other Operating Expense Chart

Fennec Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

0.20

0.39

Fennec Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Operating Expense	Get a 7-Day Free Trial															0.09	0.10	-	0.10	0.09

Fennec Pharmaceuticals Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.29 Mil.

Fennec Pharmaceuticals Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Fennec Pharmaceuticals's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Fennec Pharmaceuticals (TSX:FRX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fennec Pharmaceuticals Inc (TSX:FRX) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

FENC:USA RV41:Germany

Address

68 TW Alexander Drive, PO Box 13628, Research Triangle Park, NC, USA, 27709

Website

https://www.fennecpharma.com

Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is engaged in research and development activities. The company is developing Sodium Thiosulfate (STS), a chemo-protectant against hearing loss associated with platinum-based chemotherapy. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin induced hearing loss, or ototoxicity in children. The company principally operates in the United States.